EPIVAX THERAPEUTICS
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97231957
- Registration number
- 7589217
- Mark type
- Stylized text
- Filed
- 21 Jan 2022
- Published for opposition
- 06 Dec 2022
- Registered
- 03 Dec 2024
- Attorney of record
- Cheryl A. Clarkin, Esq.
Goods and services
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines; Pharmaceutical research and development; Vaccine research and development
Owner
- EpiVax, Inc., Providence, RI, US
- EpiVax, Inc., Providence, RI, US
- EpiVax, Inc., Providence, RI, US
Prior registrations
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Feb 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 14 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jan 2024 — USE AMENDMENT FILED
- 08 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 24 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jun 2023 — SOU EXTENSION 1 GRANTED
- 22 Jun 2023 — SOU EXTENSION 1 FILED
- 22 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 31 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED